Search results
Showing 61 to 75 of 136 results for sclerosis
Rehabilitation for chronic neurological disorders including acquired brain injury (NG252)
This guideline covers rehabilitation in all settings for children, young people and adults with a chronic neurological disorder, neurological impairment or disabling neurological symptoms due to acquired brain injury, acquired spinal cord injury, acquired peripheral nerve disorder, functional neurological disorder or progressive neurological disease.
Show all sections
Sections for NG252
- Overview
- Designing and commissioning rehabilitation services
- Assessing rehabilitation needs and goal setting
- Rehabilitation planning and delivery
- Information, advice and learning as part of rehabilitation
- Rehabilitation to maintain, improve or support function
- Rehabilitation to support education, work, social and leisure activities, relationships and sex
- Terms used in this guideline
Fenebrutinib for treating relapsing multiple sclerosis [ID6577]
Awaiting development Reference number: GID-TA11775 Expected publication date: TBC
ODFS Pace and Pace XL functional electrical stimulation devices for treating drop foot (MIB56)
NICE has developed a medtech innovation briefing (MIB) on the ODFS Pace and Pace XL functional electrical stimulation devices for treating drop foot
Can vitamin D slow down the progression of disability in Multiple Sclerosis (MS)?
Can vitamin D slow down the progression of disability in Multiple Sclerosis (MS)? Any explanatory notes(if applicable) Despite...
NICE recommends the development of patient registries for multiple sclerosis to capture long-term treatment-related outcomes. Any...
cost effectiveness of cognitive rehabilitation for people with Multiple sclerosis (MS)? Any explanatory notes(if applicable) Cognitive...
inform future cost-effectiveness models of relapsing-remitting multiple sclerosis. In particular, this research should include a more...
Find out what guidance is being considered for development
Percutaneous posterior tibial nerve stimulation for overactive bladder syndrome (HTG235)
Evidence-based recommendations on percutaneous posterior tibial nerve stimulation for overactive bladder syndrome. This involves inserting a fine needle into a nerve just above the ankle and passing a mild electric current to the nerves that control bladder function.
View recommendations for HTG235Show all sections
Sections for HTG235
interventions are effective in reducing spasticity in people with Multiple Sclerosis (MS)? Any explanatory notes(if applicable)...
This indicator covers the percentage of patients with moderate or severe frailty and/or multimorbidity who have received a medication review in the last 12 months which is structured, has considered the use of a recognised tool and taken place as a shared discussion. It measures outcomes that reflect the quality of care or processes linked by evidence to improved outcomes. This indicator was previously published as NM186
This guideline covers assessing and managing faecal incontinence (any involuntary loss of faeces that is a social or hygienic problem) in people aged 18 and over. It aims to ensure that staff are aware that faecal incontinence is a sign or a symptom, not a diagnosis. It aims to improve the physical and mental health and quality of life of people with faecal incontinence.
and form of rehabilitation for mobility problems in people with Multiple Sclerosis (MS)? Any explanatory notes(if applicable) Reduced...
Evidence-based recommendations on injectable bulking agents for faecal incontinence. This involves injecting a material into the muscles around the anus to bulk the sides of the sphincter.
View recommendations for HTG135Show all sections
Sections for HTG135
Discontinued Reference number: GID-TA11476